Oncolytics Biotech (ONCY) Income from Non-Controlling Interests (2011 - 2012)
Oncolytics Biotech's (ONCY) quarterly Income from Non-Controlling Interests came in at -$47462.0 in Q3 2012, down 595.07% year-on-year from $9587.0 in Q4 2011, and down 140.85% on a QoQ basis from $116200.0 in Q2 2012.
Oncolytics Biotech (ONCY) Income from Non-Controlling Interests (2011 - 2012) Analysis & Trends
Oncolytics Biotech (ONCY) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$47462.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Oncolytics Biotech | 76.70 Mn | 76.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | -47,462.00 |
| Jun 30, 2012 | 116,200.00 |
| Sep 30, 2011 | 9,587.00 |
| Jun 30, 2011 | -75,211.00 |